1. Aboud-Pirak, E, Hurwitz, E, Pirak, ME, Bellot, F, Schlessinger, J & Sela, M (1988). Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J Natl Cancer Inst 80: 1605–1611.
2. Bianco, C, Tortora, G, Baldassarre, G, Caputo, R, Fontanini, G, Chinè, S, Bianco, AR & Ciardiello, F (1997). 8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer. Clin Cancer Res 3: 439–448.
3. Bosanquet, AG, Buriton, AR, Bell, PB & Harris, AL (1997). Ex vivo cytotoxic drug evalutation by DISC assay to expedite identification of clinical targets: results with 8-chloro-cAMP. Br J Cancer 76: 511–518.
4. Budillon, A, Tagliaferri, P, Caraglia, M, Torrisi, MR, Normanno, N, Iacobelli, S, Palmieri, G, Stoppelli, MP, Frati, L & Bianco, AR (1991). Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells. Cancer Res 51: 1294–1299.
5. Budillon, A, Cereseto, A, Kondrashin, A, Nesterova, M, Merlo, G, Clair, T & Cho-Chung, YS (1995). Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RIIβ regulatory subunit to lose its ability to revert transformed fibroblasts. Proc Natl Acad Sci USA 92: 10634–10638.